Danish Pharmaceutical Company to Expand Its Greater Boston Presence

Danish pharmaceutical company Novo Nordisk announced that it will be expanding its Research & Development operations in the Greater Boston area, bringing more than 200 new jobs to its Watertown, Cambridge and Lexington branches. You can read more about it [here](https://www.biospace.com/article/novo-boosts-boston-r-and-d-operations-with-new-r-and-d-site-adds-200-jobs/). Novo Nordisk is investing heavily in the Boston area. In November, they announced their plans to convert a 100,000 sq ft space into a state-of-the-art lab focusing on their RNA interference research. They’ve become a huge player in this space after acquiring Dicerna Pharmaceuticals, also based out of Lexington, in November of 2021. With new jobs being created in the area, coupled with very low inventory, it is already promising to be an extremely competitive spring market. Track record and experience matter more than ever. With a combined 50+ years in the Greater Boston market with over $1 Billion in Real Estate sold, you can trust you will be in good hands with my team and I. Contact me to get started! * * *